PP
BIO icon

PDT Partners’s Bio-Rad Laboratories Class A BIO Stock Holding History

PDT Partners’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-501
Closed -$248K – 851
2022
Q2 		$248K Buy
+501
New +$261K 0.02% 787
2015
Q3 		– Sell
-5,411
Closed -$815K – 1274
2015
Q2 		$815K Buy
+5,411
New +$774K 0.02% 802
2014
Q4 		– Sell
-15,472
Closed -$1.75M – 665
2014
Q3 		$1.75M Buy
+15,472
New +$1.83M 0.04% 460
2013
Q4 		– Sell
-2,700
Closed -$317K – 674
2013
Q3 		$317K Sell
2,700
-5,869
-68% -$692K 0.01% 1225
2013
Q2 		$961K Buy
+8,569
New +$1.01M 0.02% 830

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return